On April 26, 2013, the U.S. Food and Drug Administration (FDA) issued a safety alert regarding the anti-seizure medication Potiga (ezogabine). Potiga is used to treat partial-onset seizures in adults with epilepsy. Epilepsy is a brain disorder that causes recurring seizures. Approximately 60,000people in Connecticut have epilepsy. One out of every ten people will experience a seizure at some point in their lives. [...]
Twiiter - Follow me
Whats Happening Now?
- Chuck Carmen published Depression common among children with temporal lobe epilepsy9 hours ago · comment (0)
- EpilepsyUni published SCAM ALERT: A Man's "Seizure Dog" Business is a Sham says NY State Supreme Court14 hours ago · comment (0)
- EpilepsyUni published Was Michael Crichton right about a link between epilepsy and violence?2 days ago · comment (0)
- Chuck Carmen published Autism Risk Rises With Prenatal Valproate Exposure6 days ago · comment (0)
- EpilepsyUni published British Survey Shows That Public Epilepsy Knowledge Has Not Been Growing7 days ago · comment (0)
- Chuck Carmen published UCB : and IBM Collaborate to Personalize Care for Epilepsy Patients
- Chuck Carmen published Scientists discover a link between epilepsy and autism for the first time!
- Chuck Carmen published IRS' theft of Medical Records affects 1 out of 25 Adult Americans
- EpilepsyUni published Perampanel Shows Promise In Patients With Difficult-To-Treat Partial Epilepsy
- EpilepsyUni published Missing link between over-stimulation and destruction of brain tissue identified
- EpilepsyUni published UA researchers discover genetic mutations that cause severe epilepsies in children
- EpilepsyUni published Study: Hypersensitivity to motion may provide clues to fundamental cause of autism
- Chuck Carmen published Scientists Link Gene Faults To Severe Childhood Epilepsies15 days ago · comment (0)